Pengyu Huang
Company: Simcere Pharmaceutical Group Limited
Job title: Director, Head In Vivo Pharmacology
Seminars:
Enhancing Safety & Efficacy: sCD70-Armored CAR-T Cells 2:45 pm
The study introduces a novel sCD70-armored CAR-T construct that improves CAR-T cell expansion, memory, ultimately enhancing antitumor efficacy This sCD70 CAR-T demonstrated superior in vivo performance with sustained cytotoxicity, and significant tumor control compared to unarmored CAR-T cells When compared to existing armor methods, this novel armor design shows potential to address safety concerns while…Read more
day: Day 2 PM
Chair’s Opening Remarks 8:50 am
day: Day 2 AM